| |
|
|
|
Agile Therap  
|
|
2.82 -0.08 (-0.03%) |
05-29 16:00 |
|
Open: |
2.96 |
Pre close: |
2.9 |
Target:
|
3.91
|
|
High: |
3.01 |
Low: |
2.76 |
Resistance:
|
3.35
3.91
|
|
Volume: |
1,522,958 |
Market Cap: |
246M |
Support:
|
2.60
2.14
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.93
 |
MACD |
MACD(12,26):
|
0.15 |
|
MA(20): |
2.77  |
Signal(12,26,9): |
0.15 |
|
MA(100): |
2.70 |
Stochastic Oscillator |
%K(14,3):
|
67.70 |
|
MA(250): |
1.97 |
%D(3): |
77.51 |
|
Average Volume(K) |
3-Month: |
247297
|
52-Week |
High:
|
4.76 |
|
10-Days: |
198002 |
Low: |
0.35 |
|
RSI |
RSI(14):
|
54.55 |
Change(%): |
133.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.368 |
Return on Equity (ttm) |
-37.9 |
Shares Out. (M) |
87.21 |
|
EPS Est. Current Year |
-1.020 |
Return on Assets (ttm) |
-20.1 |
Shares Float (M) |
65.55 |
|
EPS Est. Next Year |
-0.980 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.69 |
|
EPS Est. Next Quarter |
-0.260 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
38.86 |
|
Forward EPS |
-0.580 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2050 |
|
Book Value (p.s.) |
1.040 |
EBITDA (p.s.) |
-0.248 |
P/E |
-7.66 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.71 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-18.61 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-10.86 |
P/CF |
-13.22 |
|
|
|
|
|
|
